Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Treatment of Lung Adenocarcinoma With Bronchioloalveolar Feature

This study has been completed.
Sponsor:
Collaborator:
AstraZeneca
Information provided by:
Intergroupe Francophone de Cancerologie Thoracique
ClinicalTrials.gov Identifier:
NCT00198380
First received: September 13, 2005
Last updated: April 28, 2010
Last verified: April 2010